Treatment of Itchy Skin in Adults with Prurigo Nodularis


STUDY BASICS

Have you been diagnosed with prurigo nodularis (PN)? If so, you may be eligible to participate in a study to help researchers evaluate an investigational drug called serlopitant, which is being tested for the treatment of itching in people with PN. Involves about 7 in-person visits and 1-2 scheduled phone calls.


IRB:
  33133/37 - A Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults With Prurigo Nodularis

Age Range
AGE:   18 and Up

Duration DURATION:  15-19 weeks
VISITS:  About 7 in-person visits

Location LOCATION: 
Falk Medical Building - Oakland

Compensation COMPENSATION: 
Up to $510.00
I'M INTERESTED
SHARE STUDY
Email A FriendEmail A Friend   FacebookFacebook   TwitterTwitter   Linked-InLinked-In


Pitt+Me

This website is maintained by the Clinical and Translational Science Institute.
© Copyright 2018, University of Pittsburgh. All rights reserved.